SEC Form SC 13D/A filed by Healthcare Capital Corp. common stock (Amendment)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

SCHEDULE 13D

(Rule 13d-101)

Information to be Included in Statements Filed Pursuant to § 240.13d-1(a) and Amendments Thereto Filed Pursuant to § 240.13d-2(a)

Under the Securities Exchange Act of 1934*

(Amendment No. 1)*

VISION HYDROGEN CORPORATION

(Name of Issuer)

COMMON STOCK, PAR VALUE $.0001 PER SHARE

(Title of Class of Securities)

92837Y 101

(CUSIP Number)

Marc J. Ross, Esq.

Avital Perlman, Esq.

Sichenzia Ross Ference LLP

1185 Avenue of the Americas, 31^st Floor

New York, NY 10036

Tel: (212) 930-9700

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

April 28, 2021

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box ☐.

Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent.

1 The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(1) Based upon an aggregate of 12,897,576 shares of common stock issued and outstanding as of April 22, 2021, as set forth in the Issuer’s quarterly report on Form 10-Q as filed with the Securities and Exchange Commission on April 23, 2021. This amount does not include the exercise or conversion of other outstanding securities of the Issuer, if any, owned by other security holders.

Item 1. Security and Issuer.

This Amendment No. 1 to Schedule 13D (this “Statement”) relates to the common stock, par value $0.0001 per share (the “Common Stock”) of Vision Hydrogen Corporation, a Nevada Corporation (the “Issuer”). This Statement supplementally amends the initial statement on Schedule 13D, filed on February 4, 2021 (the “Initial Statement”) by the Reporting Person (as defined herein). This Amendment No. 1 is being filed by the Reporting Person to report that, as a result of a recent transaction, there has been a material decrease in the percentage of the class of Common Stock beneficially owned by the Reporting Person. The Issuer’s principal executive offices are located at 95 Christopher Columbus Drive, 16th Floor, Jersey City, NJ 07302. The party is referred to herein as a “Reporting Person.”

Item 2. Identity and Background.

This statement is filed on behalf of Judd Brammah, a United Kingdom citizen (“Brammah”). The principal business address of Brammah is c/o Vision Hydrogen Corporation, 95 Columbus Drive, 16th Floor, Jersey City, NJ 07302.

Brammah is a Director of the Issuer. Brammah disclaims beneficial ownership of the shares of Common Stock owned by any person other than such Reporting Person except to the extent of any pecuniary interest therein.

Brammah has not, during the past five years, been convicted in a criminal proceeding (excluding traffic violations and similar misdemeanors). Brammah has not, during the past five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

Item 3. Source and Amount of Funds or Other Consideration.

On April 28, 2021, pursuant to a securities purchase agreement between Judd Brammah and Turquino Equity LLC (“Turquino”), an entity controlled by the Issuer’s Chief Executive Officer and director, Brammah sold two hundred fifty thousand (250,000) shares to Turquino for a total purchase price of $50,000.

Item 4. Purpose of Transaction.

Brammah is a member of the Board of Directors of the Issuer. In this capacity, Brammah takes and will continue to take an active role in the Issuer’s strategic direction. Additionally, in his capacity as a stockholder of the Issuer, Brammah reviews and intends to continue to review, on an ongoing and continued basis, his investments in the Issuer. Depending on the factors discussed below and subject to applicable law, Brammah may from time to time acquire additional securities of the Issuer or otherwise dispose of some or all of such securities of the Issuer. Any transactions that Brammah may pursue may be made at any time and from time to time without prior notice and will depend upon a variety of factors, including, without limitation, current and anticipated future trading prices of the securities of the Issuer, the financial condition, results of operations and prospects of the Issuer, general economic, financial market and industry conditions, other investment and business opportunities available to Brammah, tax considerations and other factors.

The Reporting Person is filing this Amendment No. 1 to report that, as result of a recent transaction, there has been a material decrease in the percentage of the class of Common Stock beneficially owned by the Reporting Person.

Item 5. Interest in Securities of the Issuer.

Item 5 of the Initial Statement is hereby replaced in its entirety with the following:

The information contained in rows 7, 8, 9, 10, 11 and 13 on each of the cover pages of this Schedule 13D is incorporated by reference in its entirety into this Item 5.

The Reporting Person beneficially owns 2,963,928 shares of the Issuer’s Common Stock, or 23% of the Common Stock.

On April 28, 2021, pursuant to a securities purchase agreement between Judd Brammah and Turquino Equity LLC (“Turquino”), an entity controlled by the Issuer’s Chief Executive Officer and director, Brammah sold two hundred fifty thousand (250,000) shares to Turquino for a total purchase price of $50,000.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

N/A.

Item 7. Material to be Filed as Exhibits.

N/A.

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and accurate.